CLINICAL_TRIALS
trial_result
· 2017-05-05
Clinical Trial Update: Tecfidera Slow-Titration Study [Phase 3]
Summary
A Phase III trial of Tecfidera (dimethyl fumarate) with slow titration in multiple sclerosis was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 3 | Status: TERMINATED | Results posted: 2017-05-05